SEC Filings

Filing date Description Form Filing Group View

25-NSE

25-NSE
Other
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425
Other
View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G
Other
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
EX-101.DEF - XBRL DEFINITION FILE View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425
Other
View HTML

Filing of certain prospectuses and communications in connection with business combination transactions

425
Other
View HTML

Form of prospectus reflecting facts events constituting substantive change from last form

424B3
Registration Statements
View HTML

EFFECT

EFFECT
Other
View HTML

Data provided by Kaleidoscope.

Top

External Link

You are now leaving the Jasper Therapeutics, Inc. site to a 3rd party website. Jasper Therapeutics is not responsible for 3rd party website content.